Related Experiment Video

Updated: Aug 20, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

Putting oncogenes into a developmental context

Dean W Felsher1

  • 1dfelsher@stanford.edu

Cancer Biology & Therapy
|December 22, 2004
PubMed

Insights

Cancer development is influenced by host developmental age. Activating the MYC oncogene in young hosts causes rapid tumor formation, while in adults, it leads to cell growth, highlighting developmental context in cancer etiology.

Area of Science:

  • Oncology
  • Developmental Biology
  • Genetics

Background:

  • Cancer arises from genomic alterations activating oncogenes or inactivating tumor suppressor genes.
  • Previous research often overlooked developmental factors in cancer etiology.
  • Experimental models have limitations in studying the role of development in tumorigenesis.

Purpose of the Study:

  • To investigate the influence of host developmental age on MYC oncogene-induced tumorigenesis.
  • To determine if developmental context impacts cancer pathogenesis.
  • To explore the relationship between genetic events, epigenetic state, and developmental factors in neoplasia.

Main Methods:

  • Utilized a conditional transgenic model system.
  • Activated the MYC oncogene at different developmental stages (embryonic, neonatal, adult).
  • Observed and compared cellular responses (proliferation vs. hypertrophy) and tumor onset.

Main Results:

  • MYC activation in embryonic and neonatal tissues resulted in rapid cellular proliferation and tumor formation.
  • MYC activation in adult tissues led to cellular hypertrophy without rapid tumorigenesis.
  • Demonstrated a significant influence of host developmental age on MYC's oncogenic potential.

Conclusions:

  • Developmental context is a critical determinant in cancer pathogenesis.
  • The timing of oncogene activation relative to host development influences cancer outcomes.
  • Cancer should be viewed as a consequence of genetic events within a permissive epigenetic and developmental state.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...